BioWorld - Saturday, April 18, 2026

BioWorld Science

Aug. 17, 2018

View Archived Issues

Neutrophil 'ghosts' drive severe asthma

Read More

To sleep, perchance to reshape your transcriptome

Read More

MicroRNA affects neuropathic pain

Read More

Targeted drug delivery using humanized Sialyl Tn-specific antibodies for ovarian cancer treatment

Read More

First patient dosed in Inovio's phase I/II study of Pennvax-GP

Read More

Release of phase IIa clinical data concerning a first-in-class drug for type 2 diabetes treatment

Read More

Metabolism targeting compound kills brain tumor cells

Read More

Development of novel broad coverage human papilloma virus vaccines

Read More

Sihuan Pharmaceutical begins phase II study of pirotinib

Read More

Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors

Read More

Fasinumab topline phase III data presented in patients with chronic pain from OA of the knee or hip

Read More

TrovaGene completes second dosing cohort in phase Ib/II study of onvansertib in AML

Read More

Lenvatinib approved in the U.S. for unresectable hepatocellular carcinoma

Read More

HitGen to collaborate with LG Chem on drug discovery using DNA-encoded libraries

Read More

Dose escalation cleared to continue in first-in-human MAGE-A4 SPEAR T-cell trial

Read More

ADAM-17 inhibitor ZLDI-8 increases cancer sensitivity to chemotherapeutic drugs

Read More

RXi Pharmaceuticals, Karolinska Institutet collaborate on sd-rxRNA for cancer immunotherapy

Read More